Prevention
To eliminate the threat of type 1 diabetes (T1D) for future generations, the JDRF Prevention Program teams up with allies in academia, industry and government to fund groundbreaking research, and then translates this knowledge into therapies that can stop T1D from developing.
Our Approach
People are being diagnosed with T1D at a growing rate. T1D is not preventable, and there is no cure—yet. At JDRF, we have developed significant knowledge about the causes of T1D. As we increase our understanding of these causes, we will also uncover ways to prevent them from occurring. Until we have found ways to prevent T1D, we must stop or slow its progression during its earliest stages.
-
![]()
Expand T1D screening
-
![]()
Delay the onset of T1D
-
![]()
Develop a vaccine
Many Paths, One Purpose
Our research into prevention technologies is just one potential pathway to finding a cure.Explore JDRF’s ambitious research portfolio. JDRF is working relentlessly to prevent, treat and cure T1D and its complications.
All ResearchGet involved and help lead us toward a cure
Prevention Progress
2015
New clues into the triggers of T1D
JDRF-supported study findings suggest researchers are narrowing in on factors that may cause T1D. The findings could be an important step toward a key JDRF goal: preventing development of T1D in at-risk individuals.
2016
Screening a path to prevention
Armed with the knowledge that T1D begins well before symptoms appear, researchers test different ways to interrupt disease progression and prevent the onset of symptoms in T1D.
2017
Intercepting and Preventing the Onset of T1D
JDRF T1D Fund invests in Provention Inc.’s lead program, which aims to potentially reduce new T1D cases by 50 percent.
2017
Collaboration to research risk factors in children
IBM and JDRF are developing machine learning methods to analyze years of global T1D research data and identify factors leading to the onset of T1D in children--the first precision medicine effort in T1D.
Looking Ahead
To date, more than $115 million has been invested by JDRF in prevention research. One day, T1D will be like polio or measles, and we will only read about it in our vaccination records.